Suphric Capsule (Cefixime Trihydrate)

Adult dose

(Capsules) ○ Adults: Administer cefixime orally at a dose of 50～100mg (potency) twice daily. For severe infections or when the response is inadequate, administer 200mg (potency) twice daily. Adjust the dose as appropriate according to age and symptoms.

Child dose

(Capsules) ○ Children weighing 30 Kg or more: Administer cefixime orally at a dose of 50～100mg (potency) twice daily. For severe infections or when the response is inadequate, administer 200mg (potency) twice daily. (Powder) ○ Children: Administer cefixime orally at a dose of 1.5～3mg (potency) per Kg of body weight twice daily. For severe infections or when the response is inadequate, administer 6mg (potency) per Kg of body weight twice daily. Adjust the dose as appropriate according to age and symptoms.

This medication should not be used in patients who have previously experienced severe allergic reactions or anaphylaxis related to this drug. It should also be avoided in patients allergic to cephalosporin antibiotics or those with genetic disorders affecting lactose metabolism. Patients with a history of allergies or poor kidney function should be particularly cautious when taking this medication, and dosage adjustments or extended dosing intervals may be necessary. Elderly patients, malnourished individuals, and patients on parenteral nutrition may face an increased risk of bleeding due to vitamin K deficiency, thus their conditions should be closely monitored. This medication contains specific dye components that individuals allergic to these substances should also use with caution. During treatment, adverse reactions such as rashes, difficulty breathing, dizziness, abdominal pain, and diarrhea may occur, and if these symptoms develop, stop taking the medication immediately and consult a healthcare professional. Additionally, severe skin disorders or renal and hepatic function abnormalities may occur infrequently, necessitating regular monitoring. This medication should only be taken for the minimum necessary duration after confirming the susceptibility of the infection-causing bacteria to prevent the development of resistant strains. Patients with impaired renal function are at risk of seizures, requiring careful dosage adjustments and monitoring. Caution should be exercised when this medication is taken in conjunction with other medications, particularly those that affect blood coagulation like warfarin. Pregnant women or those who may become pregnant should use this drug with caution, and it is advisable to avoid breastfeeding during treatment. Newborns and infants under 6 months should not use this medication as safety has not been established. Elderly patients may experience side effects more readily, so dosages and intervals should be adjusted while monitoring their status closely. Finally, it is important to inform the physician about taking this medication during tests, as it may affect test results.

Shock

This medication should be stored in a tightly sealed container to prevent air or moisture ingress, preferably at room temperature between 1 and 30 degrees Celsius. This storage method helps maintain the drug's effectiveness.

Appearance

A hard capsule with a light orange color containing a white to light yellow crystalline powder

Package unit

30 capsules/bottle, 100 capsules/bottle